Researchers have discovered how a surface protein on brain cells, called Aplp1, can play a role in spreading material responsible for Parkinson's disease from cell to cell in the brain. Promisingly, an FDA-approved cancer drug that targets another …

Basel: Roche has announced its decision to proceed with Phase III development of prasinezumab, an investigational anti-alpha-synuclein antibody, in early-stage Parkinson’s disease. This decision is informed by data from the Phase IIb PADOVA study and …

The event, organised by Worcester-based accountancy and advisory group Hayward Wright, took place at Shirley Golf Club in Solihull and attracted more than 135 participants from organisations across the Midlands. It was the third year of the event, which …

Roche announced its decision to proceed with phase III development of prasinezumab, an investigational anti-alpha-synuclein antibody, in early-stage Parkinson’s disease. This decision is informed by data from the phase IIb PADOVA study and ongoing open- …

For many homeowners, a property surrounded by greenery, open space and a sense of community is the ultimate lifestyle prize. The appeal is obvious: proximity to nature, low-traffic streets, and easy access to outdoor leisure pursuits create a sense of …

(MENAFN- GlobeNewsWire - Nasdaq) Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage Parkinson's disease Prasinezumab is a potential first-in-class anti-alpha-synuclein …

Prothena Corporation plc (NASDAQ:PRTA) today announced partner Roche will advance prasinezumab, an investigational anti-alpha-synuclein antibody, into Phase III development in early-stage Parkinson’s disease. This decision is informed by data from the …

CINCINNATI (WKRC) - The Cincinnati Ballet, in collaboration with Parkinson Support and Wellness, hosted an event at the Margaret and Michael Valentine Center for Dance, focusing on performers with Parkinson's disease. The afternoon featured live …

Trnava University via Unsplash Researchers testing samples About 153,000 people in the UK are currently living with Parkinson’s, a neurodegenerative condition that mostly affects the dopamine-producing neurons found in a part of the brain called the …

Brett Favre is once again stepping into uncharted territory-this time not on the field, but in the world of neurological recovery as the NFL Hall of Famer aims to fight off Parkinson's disease. The legendary quarterback, known for his unmatched …